These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 858916

  • 41. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A, Boumsell L, Borsos.
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [Abstract] [Full Text] [Related]

  • 42. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ, Frank MM.
    J Immunol; 1986 Jul 15; 137(2):625-30. PubMed ID: 3722818
    [Abstract] [Full Text] [Related]

  • 43. [Anticomplementary activity of a polyanion: pentosan-poly-sulfoester, II.--Mode of action and "in vitro " inhibition of human complement hemolytic activity (author's transl)].
    Berthoux FX, Freyria AM, Traeger J.
    Pathol Biol (Paris); 1977 Feb 15; 25(2):105-8. PubMed ID: 322041
    [Abstract] [Full Text] [Related]

  • 44. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
    Rothlein R, Springer TA.
    J Immunol; 1985 Oct 15; 135(4):2668-72. PubMed ID: 3897377
    [Abstract] [Full Text] [Related]

  • 45. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 46. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S, Gewurz H, Mold C.
    J Immunol; 1986 Feb 15; 136(4):1354-9. PubMed ID: 3944459
    [Abstract] [Full Text] [Related]

  • 47. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W, Stankiewicz M.
    Arch Immunol Ther Exp (Warsz); 1986 Feb 15; 34(4):451-60. PubMed ID: 3099725
    [Abstract] [Full Text] [Related]

  • 48. Antimitogenic actions of lectins in cultured human fibroblasts.
    Kaplowitz PB, Haar JL.
    J Cell Physiol; 1988 Jul 15; 136(1):13-22. PubMed ID: 3260901
    [Abstract] [Full Text] [Related]

  • 49. Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse.
    Bullens RW, Halstead SK, O'Hanlon GM, Veitch J, Molenaar PC, Willison HJ, Plomp JJ.
    Muscle Nerve; 2005 Jun 15; 31(6):751-60. PubMed ID: 15793847
    [Abstract] [Full Text] [Related]

  • 50. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP, Frank MM.
    J Clin Invest; 1974 Aug 15; 54(2):339-48. PubMed ID: 4847248
    [Abstract] [Full Text] [Related]

  • 51. Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.
    Zhang Y, Suankratay C, Zhang X, Jones DR, Lint TF, Gewurz H.
    Immunology; 1999 Aug 15; 97(4):686-92. PubMed ID: 10457224
    [Abstract] [Full Text] [Related]

  • 52. Lymphokine and synthesis of complement by guinea pig spleen cells.
    Cambier A, Peltier AP.
    Biomedicine; 1978 Dec 15; 28(6):332-6. PubMed ID: 747725
    [Abstract] [Full Text] [Related]

  • 53. The inhibition capacity of concanavalin A on monomeric and polymeric hemolytic antibodies.
    Moţa G.
    Mol Immunol; 1985 Dec 15; 22(12):1359-63. PubMed ID: 3879528
    [Abstract] [Full Text] [Related]

  • 54. Succinylated and acetylated concanavalin A activate the classical complement pathway.
    Langone JJ, Ejzemberg R.
    Biochem Biophys Res Commun; 1981 Apr 15; 99(3):768-74. PubMed ID: 7247942
    [No Abstract] [Full Text] [Related]

  • 55. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
    Loos M, Bitter-Suermann D.
    Immunology; 1976 Dec 15; 31(6):931-4. PubMed ID: 186401
    [Abstract] [Full Text] [Related]

  • 56. A simplified method for the preparation of EAC14.
    Matre R, Tönder O, Wesenberg F.
    J Immunol Methods; 1980 Dec 15; 39(1-2):25-9. PubMed ID: 7007511
    [Abstract] [Full Text] [Related]

  • 57. Identification of RNA as a complement inhibitory component in an extract of Ehrlich ascites tumor cells.
    Renk CM, Hoffmann EM.
    J Immunol; 1977 Jul 15; 119(1):263-70. PubMed ID: 326959
    [Abstract] [Full Text] [Related]

  • 58. A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone.
    Kitamura F, Shimada K, Suzuki T, Nishioka K.
    J Immunol Methods; 1985 Dec 27; 85(2):363-70. PubMed ID: 3908568
    [Abstract] [Full Text] [Related]

  • 59. Modification of the biological activities of concanavalin A by anti-concanavalin A.
    Leon MA.
    Adv Exp Med Biol; 1975 Dec 27; 55():261-71. PubMed ID: 1171587
    [Abstract] [Full Text] [Related]

  • 60. The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.
    Goers JW, Porter RR.
    Biochem J; 1978 Nov 01; 175(2):675-84. PubMed ID: 743217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.